INTERNATIONAL PATENT: NOVARTIS AG, KORDIKOWSKI, ANDREAS, REGGANE, MAUDE FILES APPLICATION FOR "DOSING REGIMENS FOR N-(3-CYANO-5-(CYCLOHEXYLMETHYL)-6,6-DIMETHYL-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDIN-2-YL)-2-(4-SULFAMOYLPHENYL)ACETAMIDE FOR USE IN TREATING OR PREVENTING A DENGUE VIRUS DISEASE OR DISORDER"

GENEVA, Nov. 24 -- NOVARTIS AG (Lichtstrasse 354056 Basel), KORDIKOWSKI, Andreas (Novartis Pharma AGLichtstrasse 354056 Basel), REGGANE, Maude (Novartis Pharma AGLichtstrasse 354056 Basel) filed a patent application (PCT/IB2025/055016) for "DOSING REGIMENS FOR N-(3-CYANO-5-(CYCLOHEXYLMETHYL)-6,6-DIMETHYL-4,5,6,7-TETRAHYDROTHIENO[3,2-C]PYRIDIN-2-YL)-2-(4-SULFAMOYLPHENYL)ACETAMIDE FOR USE IN TREATING OR PREVENTING A DENGUE VIRUS DISEASE OR DISORDER" on May 13, 2025. With publication no. WO/2025/238553, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organiza...